期刊文献+

PARK基因家族在骨骼肌肌病中的研究进展 被引量:1

The roles of PARK gene family in myopathy
下载PDF
导出
摘要 PARK作为帕金森病的致病基因家族,在帕金森病的发生发展中发挥了关键作用。近年来的研究表明,这一关键基因家族在骨骼肌肌病的发生发展中也发挥着重要作用,作为运动神经元修饰剂,保护神经元的完整性,参与骨骼肌神经–肌肉接头处神经信号的传递,骨骼肌能量代谢及线粒体质量控制、同时调控肌生成因子表达,促进肌肉再生,维持肌肉含量和功能。本文主要综述了PARK基因家族在骨骼肌肌病中的研究进展,总结了骨骼肌肌病发生的分子机制及研究方向,以期为进一步研究PARK家族在骨骼肌肌病发生发展中的作用提供参考,为理解骨骼肌肌病分子病理机制及临床诊断和治疗带来新的启示。 The causative gene family of Parkinson's disease,PARK,plays important roles in the regulation of skeletal myopathy and is also involved in multiple biological processes,such as the modification of motor neurons,the transmission of nerve signals at the nerve-muscle junction,the regulation of skeletal muscle energy metabolism and mitochondrial quality,and the expression of myogenesis factors.PARK gene family regulates skeletal muscle mass,functions through a multi-level regulatory system,and plays a key role in the occurrence and development of skeletal myopathy.In this review,we summarize the structural characteristics,functions,and research of the PARK gene family in skeletal myopathy,providing a theoretical foundation and future research direction for in-depth study of the molecular mechanism for skeletal myopathy and giving references to further study on the role of PARK family in the development,the pathology,clinical diagnosis,and treatment of skeletal myopathy.
作者 张爽 郭珊珊 王汝雯 马仁燕 吴显敏 陈佩杰 王茹 Shuang Zhang;Shanshan Guo;Ruwen Wang;Renyan Ma;Xianmin Wu;Peijie Chen;Ru Wang(School of Kinesiology,Shanghai University of Sport,Shanghai 200438,China)
出处 《遗传》 CAS CSCD 北大核心 2022年第7期545-555,共11页 Hereditas(Beijing)
基金 国家重点研发计划(编号:2020YFA0803800) 国家自然科学基金委面上项目(编号:31971097) 上海市“科技创新行动计划”优秀学术/技术带头人计划(编号:21XD1403200) 中国上海前沿运动与代谢健康科学研究基地以及中医代谢疾病多学科交叉创新团队项目(编号:ZYCXTD-D-202001)资助~~
关键词 PARK基因家族 包涵体肌炎 病毒性肌炎 肌萎缩 杜氏肌营养不良 肌损伤 线粒体肌病 PARK gene family inclusion body myositis infective myositis atrophy duchenne skeletal muscle injury mitochondrial myopathy
  • 相关文献

参考文献9

二级参考文献93

  • 1Polymeropoulos MH;Lavedan C;Leroy E.Mutation in the α-synuclein gene identified in families with Parkinson' s disease[J],1997(5321).
  • 2Polymeropoulos MH;Higgins JJ;Golbe LI.Mapping of a gene for Parkinson's disease to chromosome 4q21-q23[J],1996.
  • 3Kruger R;Kuhn W;Muller T.Ala30 pro mutation in the gene encoding α-synuclein in Parkinson's disease[J],1998(2).
  • 4Dawson T;Mandir A;Lee M.Animal models of PD:pieces of the same puzzle?[J],2002(2).
  • 5Lehmensiek V;Tan EM;Schwarz J.Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+toxicity in vitro[J],2002(10).
  • 6Dauer W;Kholodilov N;Vila M.Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP[J],2002.
  • 7Mori H;Kondo T;Yokochi M.Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q,1998.
  • 8Shimura H;Schlossmacher MG;Hattori N.Ubiquitination of a new form of alpha-synuclein by parkin from human brain:implications for Parkinson's disease[J],2001.
  • 9Imai Y;Soda M;Inoue H.An unfolded putative transmembrane polypeptide,which can lead to endoplasmic reticulum stress,is a substrate of Parkin[J],2001(7).
  • 10McNaught KS;Mytilineou C;Jnobaptiste R.Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures[J],2002.

共引文献96

同被引文献19

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部